Have a personal or library account? Click to login
Genetic Risk Factors for Essential Tremor: A Review Cover

Genetic Risk Factors for Essential Tremor: A Review

Tremor and Other Hyperkinetic Movements
Volume 10 (2020): Issue 0
By: Vasileios Siokas,  Athina-Maria Aloizou,  Zisis Tsouris,  Ioannis Liampas,  Paraskevi Aslanidou,  Metaxia Dastamani,  Alexandros G. Brotis,  Dimitrios P. Bogdanos,  Georgios M. Hadjigeorgiou and  Efthimios Dardiotis  
Open Access
|Jun 2020

References

  1. 1Jankovic J. Essential tremor: a heterogenous disorder. Movement disorders: official journal of the Movement Disorder Society. 2002;17(4): 638–44. DOI: 10.1002/mds.10221
    Back to article
  2. 2Louis ED. The primary type of tremor in essential tremor is kinetic rather than postural: cross-sectional observation of tremor phenomenology in 369 cases. European journal of neurology. 2013; 20(4): 725–7. DOI: 10.1111/j.1468-1331.2012.03855.x
    Back to article
  3. 3Clark LN, Louis ED. Essential tremor. Handbook of clinical neurology. 2018; 147: 229–39. DOI: 10.1016/B978-0-444-63233-3.00015-4
    Back to article
  4. 4Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. European journal of neurology. 2007; 14(10): 1138–46. DOI: 10.1111/j.1468-1331.2007.01923.x
    Back to article
  5. 5Bermejo-Pareja F, Puertas-Martin V. Cognitive features of essential tremor: a review of the clinical aspects and possible mechanistic underpinnings. Tremor and other hyperkinetic movements (New York, NY). 2012; 2.
    Back to article
  6. 6Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A, et al. Essential pitfalls in “essential” tremor. Movement disorders: official journal of the Movement Disorder Society. 2017; 32(3): 325–31. DOI: 10.1002/mds.26919
    Back to article
  7. 7Zdrodowska MA, Cersonsky TEK, Salardini A, Cosentino S, Louis ED. Dementia in Essential Tremor: A Visual Record. Tremor and other hyperkinetic movements (New York, NY). 2019; 9: 635.
    Back to article
  8. 8Barbosa R, Mendonca M, Ladeira F, Miguel R, Bugalho P. Probable REM-Sleep Behavior Disorder and Dysautonomic Symptoms in Essential Tremor. Tremor and other hyperkinetic movements (New York, NY). 2017; 7: 522.
    Back to article
  9. 9Louis ED, Dure LS, Pullman S. Essential tremor in childhood: a series of nineteen cases. Movement disorders: official journal of the Movement Disorder Society. 2001; 16(5): 921–3. DOI: 10.1002/mds.1182
    Back to article
  10. 10Jimenez-Jimenez FJ, de Toledo-Heras M, Alonso-Navarro H, Ayuso-Peralta L, Arevalo-Serrano J, Ballesteros-Barranco A, et al. Environmental risk factors for essential tremor. European neurology. 2007; 58(2): 106–13. DOI: 10.1159/000103646
    Back to article
  11. 11Ong YL, Deng X, Tan EK. Etiologic links between environmental and lifestyle factors and Essential tremor. Annals of clinical and translational neurology. 2019; 6(5): 979–89. DOI: 10.1002/acn3.758
    Back to article
  12. 12Louis ED, Hernandez N, Rabinowitz D, Ottman R, Clark LN. Predicting age of onset in familial essential tremor: how much does age of onset run in families? Neuroepidemiology. 2013; 40(4): 269–73. DOI: 10.1159/000345253
    Back to article
  13. 13Louis ED. Environmental epidemiology of essential tremor. Neuroepidemiology. 2008; 31(3): 139–49. DOI: 10.1159/000151523
    Back to article
  14. 14Revuelta G, McGill C, Jensen JH, Bonilha L. Characterizing Thalamo-Cortical Structural Connectivity in Essential Tremor with Diffusional Kurtosis Imaging Tractography. Tremor and other hyperkinetic movements (New York, NY). 2019; 9.
    Back to article
  15. 15Jimenez-Jimenez FJ, Garcia-Martin E, Alonso-Navarro H, Lorenzo-Betancor O, Ortega-Cubero S, Pastor P, et al. A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor. Neurological research. 2016; 38(10): 880–7. DOI: 10.1080/01616412.2016.1210355
    Back to article
  16. 16Naranjo KV, Park J, Chen KP, Hernandez N, Clark LN, Ottman R, et al. Genetic Testing Preferences of Individuals in Families with Essential Tremor. Tremor and other hyperkinetic movements (New York, NY). 2018; 8: 545.
    Back to article
  17. 17Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology. 2001; 57(8): 1389–91. DOI: 10.1212/WNL.57.8.1389
    Back to article
  18. 18Chen J, Huang P, He Y, Shen J, Du J, Cui S, et al. IL1B polymorphism is associated with essential tremor in Chinese population. BMC neurology. 2019; 19(1): 99. DOI: 10.1186/s12883-019-1331-5
    Back to article
  19. 19Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nature genetics. 2009; 41(3): 277–9. DOI: 10.1038/ng.299
    Back to article
  20. 20Thier S, Lorenz D, Nothnagel M, Poremba C, Papengut F, Appenzeller S, et al. Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology. 2012; 79(3): 243–8. DOI: 10.1212/WNL.0b013e31825fdeed
    Back to article
  21. 21Muller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, et al. Genome-wide association study in essential tremor identifies three new loci. Brain: a journal of neurology. 2016; 139(Pt 12): 3163–9. DOI: 10.1093/brain/aww242
    Back to article
  22. 22DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3): 177–88. DOI: 10.1016/0197-2456(86)90046-2
    Back to article
  23. 23Siokas V, Dardiotis E, Tsironi EE, Tsivgoulis G, Rikos D, Sokratous M, et al. The Role of TOR1A Polymorphisms in Dystonia: A Systematic Review and Meta-Analysis. PloS one. 2017; 12(1): e0169934. DOI: 10.1371/journal.pone.0169934
    Back to article
  24. 24Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E, et al. BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm. Neuromolecular medicine. 2019; 21(1): 68–74. DOI: 10.1007/s12017-018-8519-5
    Back to article
  25. 25Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute. 1959; 22(4): 719–48.
    Back to article
  26. 26Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315(7109): 629–34. DOI: 10.1136/bmj.315.7109.629
    Back to article
  27. 27Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, et al. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism & related disorders. 2010; 16(2): 109–11. DOI: 10.1016/j.parkreldis.2009.08.006
    Back to article
  28. 28Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010; 11(4): 401–8. DOI: 10.1007/s10048-010-0241-x
    Back to article
  29. 29Mi S, Sandrock A, Miller RH. LINGO-1 and its role in CNS repair. The international journal of biochemistry & cell biology. 2008; 40(10): 1971–8. DOI: 10.1016/j.biocel.2008.03.018
    Back to article
  30. 30Zhao XH, Jin WL, Wu J, Mi S, Ju G. Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons. Cellular and molecular neurobiology. 2008; 28(5): 727–35. DOI: 10.1007/s10571-007-9258-6
    Back to article
  31. 31Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. European journal of human genetics: EJHG. 2010; 18(7): 838–43. DOI: 10.1038/ejhg.2010.27
    Back to article
  32. 32Louis ED, Yi H, Erickson-Davis C, Vonsattel JP, Faust PL. Structural study of Purkinje cell axonal torpedoes in essential tremor. Neuroscience letters. 2009; 450(3): 287–91. DOI: 10.1016/j.neulet.2008.11.043
    Back to article
  33. 33Tan EK, Teo YY, Prakash KM, Li R, Lim HQ, Angeles D, et al. LINGO1 variant increases risk of familial essential tremor. Neurology. 2009; 73(14): 1161–2. DOI: 10.1212/WNL.0b013e3181bacfc9
    Back to article
  34. 34Lorenzo-Betancor O, Garcia-Martin E, Cervantes S, Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, et al. Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. European journal of neurology. 2011; 18(8): 1085–9. DOI: 10.1111/j.1468-1331.2010.03251.x
    Back to article
  35. 35Zuo X, Jiang H, Guo JF, Yu RH, Sun QY, Hu L, et al. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson’s disease in Chinese population. Neuroscience letters. 2010; 481(2): 69–72. DOI: 10.1016/j.neulet.2010.06.041
    Back to article
  36. 36Liang H, Song Z, Deng X, Xu H, Zhu A, Zheng W, et al. Genetic analysis of the leucine-rich repeat and lg domain containing Nogo receptor-interacting protein 1 gene in essential tremor. Journal of molecular neuroscience: MN. 2013; 51(2): 403–7. DOI: 10.1007/s12031-013-0029-1
    Back to article
  37. 37Wu YW, Rong TY, Li HH, Xiao Q, Fei QZ, Tan EK, et al. Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta neurologica Scandinavica. 2011; 124(4): 264–8. DOI: 10.1111/j.1600-0404.2010.01466.x
    Back to article
  38. 38Radovica I, Inashkina I, Smeltere L, Vitols E, Jankevics E. Screening of 10 SNPs of LINGO1 gene in patients with essential tremor in the Latvian population. Parkinsonism & related disorders. 2012; 18(1): 93–5. DOI: 10.1016/j.parkreldis.2011.06.006
    Back to article
  39. 39Bourassa CV, Riviere JB, Dion PA, Bernard G, Diab S, Panisset M, et al. LINGO1 variants in the French-Canadian population. PloS one. 2011; 6(1): e16254. DOI: 10.1371/journal.pone.0016254
    Back to article
  40. 40Thier S, Lorenz D, Nothnagel M, Stevanin G, Durr A, Nebel A, et al. LINGO1 polymorphisms are associated with essential tremor in Europeans. Movement disorders: official journal of the Movement Disorder Society. 2010; 25(6): 717–23. DOI: 10.1002/mds.22887
    Back to article
  41. 41Wu YW, Prakash KM, Rong TY, Li HH, Xiao Q, Tan LC, et al. Lingo2 variants associated with essential tremor and Parkinson’s disease. Human genetics. 2011; 129(6): 611–5. DOI: 10.1007/s00439-011-0955-3
    Back to article
  42. 42Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene expression patterns: GEP. 2009; 9(1): 1–26. DOI: 10.1016/j.gep.2008.09.004
    Back to article
  43. 43Haines BP, Rigby PW. Expression of the Lingo/LERN gene family during mouse embryogenesis. Gene expression patterns: GEP. 2008; 8(2): 79–86. DOI: 10.1016/j.modgep.2007.10.003
    Back to article
  44. 44Liang H, Zheng W, Xu H, Lei J, Song Z, Jiang X, et al. No evidence of association between the LINGO4 gene and essential tremor in Chinese Han patients. Parkinsonism & related disorders. 2012; 18(3): 303–5. DOI: 10.1016/j.parkreldis.2011.10.017
    Back to article
  45. 45Siokas V, Fotiadou A, Dardiotis E, Kotoula MG, Tachmitzi SV, Chatzoulis DZ, et al. SLC2A1 Tag SNPs in Greek Patients with Diabetic Retinopathy and Nephropathy. Ophthalmic research. 2019; 61(1): 26–35. DOI: 10.1159/000480241
    Back to article
  46. 46Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. Journal of cellular physiology. 2011; 226(10): 2484–93. DOI: 10.1002/jcp.22609
    Back to article
  47. 47Berger UV, Hediger MA. Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anatomy and embryology. 1998; 198(1): 13–30. DOI: 10.1007/s004290050161
    Back to article
  48. 48Wu J, Lee MR, Choi S, Kim T, Choi DS. ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcoholism, clinical and experimental research. 2010; 34(6): 1110–7. DOI: 10.1111/j.1530-0277.2010.01187.x
    Back to article
  49. 49Handforth A, Kadam PA, Kosoyan HP, Eslami P. Suppression of Harmaline Tremor by Activation of an Extrasynaptic GABAA Receptor: Implications for Essential Tremor. Tremor and other hyperkinetic movements (New York, NY). 2018; 8: 546.
    Back to article
  50. 50Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Lorenzo-Betancor O, Pastor P, et al. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population. Pharmacogenetics and genomics. 2013; 23(11): 587–90. DOI: 10.1097/FPC.0b013e328364db9d
    Back to article
  51. 51Tan EK, Foo JN, Tan L, Au WL, Prakash KM, Ng E, et al. SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects. Neurology. 2013; 80(17): 1618–9. DOI: 10.1212/WNL.0b013e31828f1903
    Back to article
  52. 52Xu Y, Cao B, Chen Y, Ou R, Wei Q, Yang J, et al. SLC1A2 rs3794087 are associated with susceptibility to Parkinson’s disease, but not essential tremor, amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population. Journal of the neurological sciences. 2016; 365: 96–100. DOI: 10.1016/j.jns.2016.04.003
    Back to article
  53. 53Yu SW, Chen CM, Chen YC, Chang CW, Chang HS, Lyu RK, et al. SLC1A2 variant is associated with essential tremor in Taiwanese population. PloS one. 2013; 8(8): e71919. DOI: 10.1371/journal.pone.0071919
    Back to article
  54. 54Ross JP, Rayaprolu S, Bernales CQ, Soto-Ortolaza AI, van Gerpen J, Uitti RJ, et al. SLC1A2 rs3794087 does not associate with essential tremor. Neurobiology of aging. 2014; 35(4): 935. e9–10. DOI: 10.1016/j.neurobiolaging.2013.09.022
    Back to article
  55. 55Zhang Y, Zhao Y, Zhou X, Li K, Yi M, Guo J, et al. Assessment of Three New Loci from Genome-wide Association Study in Essential Tremor in Chinese population. Scientific reports. 2017; 7(1): 7981. DOI: 10.1038/s41598-017-08863-5
    Back to article
  56. 56Xiao B, Deng X, Ng EY, Tio M, Prakash KM, Au WL, et al. GWAS-linked PPARGC1A variant in Asian patients with essential tremor. Brain: a journal of neurology. 2017; 140(4): e24. DOI: 10.1093/brain/awx027
    Back to article
  57. 57Lucotte G, Lagarde JP, Funalot B, Sokoloff P. Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families. Clinical genetics. 2006; 69(5): 437–40. DOI: 10.1111/j.1399-0004.2006.00600.x
    Back to article
  58. 58Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Puertas I, Rubio L, et al. Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor. Movement disorders: official journal of the Movement Disorder Society. 2009; 24(13): 1910–5. DOI: 10.1002/mds.22518
    Back to article
  59. 59Gulcher JR, Jonsson P, Kong A, Kristjansson K, Frigge ML, Karason A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nature genetics. 1997; 17(1): 84–7. DOI: 10.1038/ng0997-84
    Back to article
  60. 60Ryoo HL, Pierrotti D, Joyce JN. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 1998; 13(5): 788–97. DOI: 10.1002/mds.870130506
    Back to article
  61. 61Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, et al. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2002; 27(1): 105–19. DOI: 10.1016/S0893-133X(02)00293-2
    Back to article
  62. 62Kusters CDJ, Paul KC, Guella I, Bronstein JM, Sinsheimer JS, Farrer MJ, et al. Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson’s disease. Parkinsonism & related disorders. 2018; 47: 39–44. DOI: 10.1016/j.parkreldis.2017.11.339
    Back to article
  63. 63Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(28): 10753–8. DOI: 10.1073/pnas.0508189103
    Back to article
  64. 64Inashkina I, Radovica I, Smeltere L, Vitols E, Jankevics E. Case-control study of patients with essential tremor in Latvia. European journal of neurology. 2008; 15(9): 988–90. DOI: 10.1111/j.1468-1331.2008.02225.x
    Back to article
  65. 65Tan EK, Prakash KM, Fook-Chong S, Yih Y, Chua E, Lum SY, et al. DRD3 variant and risk of essential tremor. Neurology. 2007; 68(10): 790–1. DOI: 10.1212/01.wnl.0000256773.87498.2f
    Back to article
  66. 66Vitale C, Gulli R, Ciotti P, Scaglione C, Bellone E, Avanzino L, et al. DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. European journal of neurology. 2008; 15(9): 985–7. DOI: 10.1111/j.1468-1331.2008.02164.x
    Back to article
  67. 67Lorenz D, Klebe S, Stevanin G, Thier S, Nebel A, Feingold J, et al. Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients. European journal of human genetics: EJHG. 2009; 17(6): 766–73. DOI: 10.1038/ejhg.2008.243
    Back to article
  68. 68Blair MA, Ma S, Phibbs F, Fang JY, Cooper MK, Davis TL, et al. Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism & related disorders. 2008; 14(6): 471–5. DOI: 10.1016/j.parkreldis.2007.11.002
    Back to article
  69. 69Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22–p25. Movement disorders: official journal of the Movement Disorder Society. 1997; 12(6): 859–64. DOI: 10.1002/mds.870120605
    Back to article
  70. 70Shatunov A, Sambuughin N, Jankovic J, Elble R, Lee HS, Singleton AB, et al. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain: a journal of neurology. 2006; 129(Pt 9): 2318–31. DOI: 10.1093/brain/awl120
    Back to article
  71. 71Zahorakova D, Ulmanova O, Kemlink D, Kofrankova M, Roth J, Martasek P, et al. No association with the ETM2 locus in Czech patients with familial essential tremor. Neuro endocrinology letters. 2010; 31(4): 549–52.
    Back to article
  72. 72Wetmur JG. Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden. Environmental health perspectives. 1994; 102(Suppl 3): 215–9. DOI: 10.1289/ehp.94102s3215
    Back to article
  73. 73Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Michalopoulou A, Andravizou A, et al. Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants. Environment international. 2018; 116: 122–35. DOI: 10.1016/j.envint.2018.04.008
    Back to article
  74. 74Louis ED, Applegate L, Graziano JH, Parides M, Slavkovich V, Bhat HK. Interaction between blood lead concentration and delta-amino-levulinic acid dehydratase gene polymorphisms increases the odds of essential tremor. Movement disorders: official journal of the Movement Disorder Society. 2005; 20(9): 1170–7. DOI: 10.1002/mds.20565
    Back to article
  75. 75Dogu O, Louis ED, Tamer L, Unal O, Yilmaz A, Kaleagasi H. Elevated blood lead concentrations in essential tremor: a case-control study in Mersin, Turkey. Environmental health perspectives. 2007; 115(11): 1564–8. DOI: 10.1289/ehp.10352
    Back to article
  76. 76Ayuso P, Agundez JA, Alonso-Navarro H, Martinez C, Benito-Leon J, Ortega-Cubero S, et al. Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor. Medicine. 2015; 94(24): e968. DOI: 10.1097/MD.0000000000000968
    Back to article
  77. 77Ayuso P, Martinez C, Pastor P, Lorenzo-Betancor O, Luengo A, Jimenez-Jimenez FJ, et al. An association study between Heme oxygenase-1 genetic variants and Parkinson’s disease. Frontiers in cellular neuroscience. 2014; 8: 298. DOI: 10.3389/fncel.2014.00298
    Back to article
  78. 78Zhang ZT, He YC, Ma XJ, Li DY, Lu GC. Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis. Neuroscience letters. 2014; 578: 122–7. DOI: 10.1016/j.neulet.2014.06.051
    Back to article
  79. 79Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, et al. Association of cumulative lead exposure with Parkinson’s disease. Environmental health perspectives. 2010; 118(11): 1609–13. DOI: 10.1289/ehp.1002339
    Back to article
  80. 80Agundez JAG, Garcia-Martin E, Alonso-Navarro H, Ayuso P, Esguevillas G, Benito-Leon J, et al. Delta-amino-levulinic acid dehydratase gene and essential tremor. European journal of clinical investigation. 2017; 47(5): 348–56. DOI: 10.1111/eci.12742
    Back to article
  81. 81Sazci A, Uren N, Idrisoglu HA, Ergul E. The rs2228570 Variant of the Vitamin D Receptor Gene is Associated with Essential Tremor. Neuroscience bulletin. 2019; 35(2): 362–4. DOI: 10.1007/s12264-018-0287-6
    Back to article
  82. 82Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiology of disease. 2006; 23(2): 329–41. DOI: 10.1016/j.nbd.2006.04.001
    Back to article
  83. 83Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, et al. Protective effect of LRRK2 p.R1398H on risk of Parkinson’s disease is independent of MAPT and SNCA variants. Neurobiology of aging. 2014; 35(1): 266. e5–14.
    Back to article
  84. 84Ng ASL, Ng EYL, Tan YJ, Prakash KM, Au WL, Tan LCS, et al. Case-control analysis of LRRK2 protective variants in Essential Tremor. Scientific reports. 2018; 8(1): 5346. DOI: 10.1038/s41598-018-23711-w
    Back to article
  85. 85Haugarvoll K, Toft M, Ross OA, White LR, Aasly JO, Farrer MJ. Variants in the LRRK1 gene and susceptibility to Parkinson’s disease in Norway. Neuroscience letters. 2007; 416(3): 299–301. DOI: 10.1016/j.neulet.2007.02.020
    Back to article
  86. 86Chao YX, Ng EY, Tan L, Prakash KM, Au WL, Zhao Y, et al. Lrrk2 R1628P variant is a risk factor for essential tremor. Scientific reports. 2015; 5: 9029. DOI: 10.1038/srep09029
    Back to article
  87. 87Chen H, Yuan L, Song Z, Deng X, Yang Z, Gong L, et al. Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients. Genetic testing and molecular biomarkers. 2018; 22(6): 398–402. DOI: 10.1089/gtmb.2017.0277
    Back to article
  88. 88Tan EK, Lee J, Lim HQ, Yuen Y, Zhao Y. Essential tremor and the common LRRK2 G2385R variant. Parkinsonism & related disorders. 2008; 14(7): 569–71. DOI: 10.1016/j.parkreldis.2007.12.003
    Back to article
  89. 89Clark LN, Kisselev S, Park N, Ross B, Verbitsky M, Rios E, et al. Mutations in the Parkinson’s disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor. Parkinsonism & related disorders. 2010; 16(2): 132–5. DOI: 10.1016/j.parkreldis.2009.05.008
    Back to article
  90. 90Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson’s disease: an etiologic link with essential tremor? Neurology. 2000; 54(5): 1195–8. DOI: 10.1212/WNL.54.5.1195
    Back to article
  91. 91Pigullo S, Di Maria E, Marchese R, Bellone E, Gulli R, Scaglione C, et al. Essential tremor is not associated with alpha-synuclein gene haplotypes. Movement disorders: official journal of the Movement Disorder Society. 2003; 18(7): 823–6. DOI: 10.1002/mds.10421
    Back to article
  92. 92Ross OA, Conneely KN, Wang T, Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, et al. Genetic variants of alpha-synuclein are not associated with essential tremor. Movement disorders: official journal of the Movement Disorder Society. 2011; 26(14): 2552–6. DOI: 10.1002/mds.23909
    Back to article
  93. 93Riboldi GM, Di Fonzo AB. GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells. 2019; 8(4). DOI: 10.3390/cells8040364
    Back to article
  94. 94Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, et al. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles. Blood cells, molecules & diseases. 2007; 38(3): 287–93. DOI: 10.1016/j.bcmd.2006.11.003
    Back to article
  95. 95Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, et al. Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2013; 20(2): 217–9. DOI: 10.1016/j.jocn.2012.01.055
    Back to article
  96. 96Im SY, Kim YE, Kim YJ. Genetics of Progressive Supranuclear Palsy. Journal of movement disorders. 2015; 8(3): 122–9. DOI: 10.14802/jmd.15033
    Back to article
  97. 97Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson’s disease. Annals of neurology. 2007; 62(2): 137–44. DOI: 10.1002/ana.21157
    Back to article
  98. 98Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Archives of neurology. 2008; 65(4): 460–4. DOI: 10.1001/archneur.65.4.460
    Back to article
  99. 99Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, et al. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology. 2011; 76(7): 670–2. DOI: 10.1212/WNL.0b013e31820c30c1
    Back to article
  100. 100Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Lorenzo-Betancor O, Pastor P, et al. H1-MAPT and the risk for familial essential tremor. PloS one. 2012; 7(7): e41581. DOI: 10.1371/journal.pone.0041581
    Back to article
  101. 101Clark LN, Liu X, Parmalee NL, Hernandez N, Louis ED. The microtubule associated protein tau H1 haplotype and risk of essential tremor. European journal of neurology. 2014; 21(7): 1044–8. DOI: 10.1111/ene.12335
    Back to article
  102. 102Dardiotis E, Aloizou AM, Siokas V, Patrinos GP, Deretzi G, Mitsias P, et al. The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis. Journal of molecular neuroscience: MN. 2018; 66(4): 617–28. DOI: 10.1007/s12031-018-1204-1
    Back to article
  103. 103Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. The Lancet Neurology. 2010; 9(10): 995–1007. DOI: 10.1016/S1474-4422(10)70195-2
    Back to article
  104. 104Merner ND, Girard SL, Catoire H, Bourassa CV, Belzil VV, Riviere JB, et al. Exome sequencing identifies FUS mutations as a cause of essential tremor. American journal of human genetics. 2012; 91(2): 313–9. DOI: 10.1016/j.ajhg.2012.07.002
    Back to article
  105. 105Rajput A, Rajput AH, Rajput ML, Encarnacion M, Bernales CQ, Ross JP, et al. Identification of FUS p.R377W in essential tremor. European journal of neurology. 2014; 21(2): 361–3. DOI: 10.1111/ene.12231
    Back to article
  106. 106Wu YR, Foo JN, Tan LC, Chen CM, Prakash KM, Chen YC, et al. Identification of a novel risk variant in the FUS gene in essential tremor. Neurology. 2013; 81(6): 541–4. DOI: 10.1212/WNL.0b013e31829e700c
    Back to article
  107. 107Ortega-Cubero S, Lorenzo-Betancor O, Lorenzo E, Alonso E, Coria F, Pastor MA, et al. Fused in Sarcoma (FUS) gene mutations are not a frequent cause of essential tremor in Europeans. Neurobiology of aging. 2013; 34(10): 2441. e9–.e11. DOI: 10.1016/j.neurobiolaging.2013.04.024
    Back to article
  108. 108Parmalee N, Mirzozoda K, Kisselev S, Merner N, Dion P, Rouleau G, et al. Genetic analysis of the FUS/TLS gene in essential tremor. European journal of neurology. 2013; 20(3): 534–9. DOI: 10.1111/ene.12023
    Back to article
  109. 109Labbe C, Soto-Ortolaza AI, Rayaprolu S, Harriott AM, Strongosky AJ, Uitti RJ, et al. Investigating the role of FUS exonic variants in essential tremor. Parkinsonism & related disorders. 2013; 19(8): 755–7. DOI: 10.1016/j.parkreldis.2013.03.005
    Back to article
  110. 110Zheng W, Deng X, Liang H, Song Z, Gao K, Yang Y, et al. Genetic analysis of the fused in sarcoma gene in Chinese Han patients with essential tremor. Neurobiology of aging. 2013; 34(8): 2078. e3–4. DOI: 10.1016/j.neurobiolaging.2013.03.001
    Back to article
  111. 111Hopfner F, Stevanin G, Muller SH, Mundwiller E, Bungeroth M, Durr A, et al. The impact of rare variants in FUS in essential tremor. Movement disorders: official journal of the Movement Disorder Society. 2015; 30(5): 721–4. DOI: 10.1002/mds.26145
    Back to article
  112. 112Guengerich FP. Cytochrome p450 enzymes in the generation of commercial products. Nature Reviews Drug Discovery. 2002; 1(5): 359–66. DOI: 10.1038/nrd792
    Back to article
  113. 113Davis DA. CME and the pharmaceutical industry: two worlds, three views, four steps. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004; 171(2): 149–50. DOI: 10.1503/cmaj.1040361
    Back to article
  114. 114Alonso-Navarro H, Martinez C, Garcia-Martin E, Benito-Leon J, Garcia-Ferrer I, Vazquez-Torres P, et al. CYP2C19 polymorphism and risk for essential tremor. European neurology. 2006; 56(2): 119–23. DOI: 10.1159/000095702
    Back to article
  115. 115Pal PK. Guidelines for management of essential tremor. Annals of Indian Academy of Neurology. 2011; 14(Suppl 1): S25–8. DOI: 10.4103/0972-2327.83097
    Back to article
  116. 116Martinez C, Garcia-Martin E, Alonso-Navarro H, Jimenez-Jimenez FJ, Benito-Leon J, Garcia-Ferrer I, et al. Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor. Neuromolecular medicine. 2007; 9(2): 195–204. DOI: 10.1007/BF02685892
    Back to article
  117. 117Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. British journal of clinical pharmacology. 2002; 53(2): 111–22. DOI: 10.1046/j.0306-5251.2001.01548.x
    Back to article
  118. 118Agundez JA, Jimenez-Jimenez FJ, Tejeda R, Ledesma MC, Orti-Pareja M, Gasalla T, et al. CYP2D6 polymorphism is not associated with essential tremor. European neurology. 1997; 38(2): 99–104. DOI: 10.1159/000113168
    Back to article
  119. 119Dardiotis E, Siokas V, Pantazi E, Dardioti M, Rikos D, Xiromerisiou G, et al. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Neurobiology of aging. 2017; 53: 194. e13–.e22. DOI: 10.1016/j.neurobiolaging.2017.01.015
    Back to article
  120. 120Yeh FL, Hansen DV, Sheng M. TREM2, Microglia, and Neurodegenerative Diseases. Trends in molecular medicine. 2017; 23(6): 512–33. DOI: 10.1016/j.molmed.2017.03.008
    Back to article
  121. 121Rikos D, Siokas V, Aloizou AM, Tsouris Z, Aslanidou P, Koutsis G, et al. TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort. Multiple sclerosis and related disorders. 2019; 35: 116–8. DOI: 10.1016/j.msard.2019.07.007
    Back to article
  122. 122Ortega-Cubero S, Lorenzo-Betancor O, Lorenzo E, Agundez JA, Jimenez-Jimenez FJ, Ross OA, et al. TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study. Parkinsonism & related disorders. 2015; 21(3): 306–9. DOI: 10.1016/j.parkreldis.2014.12.010
    Back to article
  123. 123Emamalizadeh B, Jamshidi J, Movafagh A, Ohadi M, Khaniani MS, Kazeminasab S, et al. RIT2 Polymorphisms: Is There a Differential Association? Molecular neurobiology. 2017; 54(3): 2234–40. DOI: 10.1007/s12035-016-9815-4
    Back to article
  124. 124Ledesma MC, Garcia-Martin E, Alonso-Navarro H, Martinez C, Jimenez-Jimenez FJ, Benito-Leon J, et al. The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor. Neuromolecular medicine. 2008; 10(4): 356–61. DOI: 10.1007/s12017-008-8040-3
    Back to article
  125. 125Keeling BH, Vilarino-Guell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, et al. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson’s disease or essential tremor. Parkinsonism & related disorders. 2010; 16(2): 112–4. DOI: 10.1016/j.parkreldis.2009.08.011
    Back to article
  126. 126Siokas V, Aloizou AM, Tsouris Z, Michalopoulou A, Mentis AA, Dardiotis E. Risk Factor Genes in Patients with Dystonia: A Comprehensive Review. Tremor and other hyperkinetic movements (New York, NY). 2018; 8: 559.
    Back to article
  127. 127Sazci A, Ergul E, Bayulkem K. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey. Movement disorders: official journal of the Movement Disorder Society. 2004; 19(12): 1472–6. DOI: 10.1002/mds.20254
    Back to article
  128. 128Chen CM, Hou YT, Liu JY, Wu YR, Lin CH, Fung HC, et al. PPP2R2B CAG repeat length in the Han Chinese in Taiwan: Association analyses in neurological and psychiatric disorders and potential functional implications. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2009; 150b(1): 124–9. DOI: 10.1002/ajmg.b.30785
    Back to article
  129. 129Martinez C, Garcia-Martin E, Alonso-Navarro H, Benito-Leon J, Puertas I, Rubio L, et al. Glutathione-S-transferase P1 polymorphism and risk for essential tremor. European journal of neurology. 2008; 15(3): 234–8. DOI: 10.1111/j.1468-1331.2007.02040.x
    Back to article
  130. 130Dardiotis E, Aloizou AM, Siokas V, Tsouris Z, Rikos D, Marogianni C, et al. Paraoxonase-1 genetic polymorphisms in organophosphate metabolism. Toxicology. 2019; 411: 24–31. DOI: 10.1016/j.tox.2018.10.012
    Back to article
  131. 131Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicology. 2013; 307: 115–22. DOI: 10.1016/j.tox.2012.07.011
    Back to article
  132. 132Deng H, Xie WJ, Le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neuroscience letters. 2006; 401(1–2): 16–9. DOI: 10.1016/j.neulet.2006.02.066
    Back to article
  133. 133Thier S, Kuhlenbaumer G, Lorenz D, Nothnagel M, Nebel A, Christensen K, et al. GABA(A) receptor- and GABA transporter polymorphisms and risk for essential tremor. European journal of neurology. 2011; 18(8): 1098–100. DOI: 10.1111/j.1468-1331.2010.03308.x
    Back to article
  134. 134Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharmacogenetics and genomics. 2011; 21(7): 436–9. DOI: 10.1097/FPC.0b013e328345bec0
    Back to article
  135. 135Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. Journal of neurology. 2011; 258(2): 203–11. DOI: 10.1007/s00415-010-5708-z
    Back to article
  136. 136Deng H, Le WD, Guo Y, Huang MS, Xie WJ, Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology. 2005; 65(4): 651–2. DOI: 10.1212/01.wnl.0000173033.32535.23
    Back to article
  137. 137Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Tan EK, Rooney JP. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology. 2005; 64(3): 417–21. DOI: 10.1212/01.WNL.0000153481.30222.38
    Back to article
  138. 138Martinez C, Garcia-Martin E, Alonso-Navarro H, Benito-Leon J, Puertas I, Rubio L, et al. Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor. Clinical neuropharmacology. 2007; 30(4): 196–200.
    Back to article
  139. 139Pigullo S, Di Maria E, Marchese R, Assini A, Bellone E, Scaglione C, et al. No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients. Journal of neural transmission (Vienna, Austria: 1996). 2001; 108(3): 297–304. DOI: 10.1007/s007020170075
    Back to article
  140. 140Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA. SLC1A2 rs3794087 variant and risk for essential tremor: a systematic review and meta-analysis. Pharmacogenetics and genomics. 2015; 25(11): 564–8. DOI: 10.1097/FPC.0000000000000171
    Back to article
  141. 141Jimenez-Jimenez FJ, Garcia-Martin E, Lorenzo-Betancor O, Pastor P, Alonso-Navarro H, Agundez JA. LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. Journal of the neurological sciences. 2012; 317(1–2): 52–7. DOI: 10.1016/j.jns.2012.02.030
    Back to article
  142. 142Kuhlenbaumer G, Hopfner F, Deuschl G. Genetics of essential tremor: meta-analysis and review. Neurology. 2014; 82(11): 1000–7. DOI: 10.1212/WNL.0000000000000211
    Back to article
  143. 143Mao X, Wang T, Liu M, Chang X, Li N, Gu Y, et al. Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2013; 20(12): 1644–9. DOI: 10.1016/j.jocn.2013.03.023
    Back to article
  144. 144Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Movement disorders: official journal of the Movement Disorder Society. 1998; 13(Suppl 3): 2–23. DOI: 10.1002/mds.870131303
    Back to article
  145. 145Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria for essential tremor: a population perspective. Archives of neurology. 1998; 55(6): 823–8. DOI: 10.1001/archneur.55.6.823
    Back to article
  146. 146Louis ED, Jiang W, Pellegrino KM, Rios E, Factor-Litvak P, Henchcliffe C, et al. Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology. 2008; 29(2): 294–300. DOI: 10.1016/j.neuro.2007.12.001
    Back to article
  147. 147Jankovic J. Essential tremor: clinical characteristics. Neurology. 2000; 54(11 Suppl 4): S21–5.
    Back to article
  148. 148Louis ED, Ottman R, Ford B, Pullman S, Martinez M, Fahn S, et al. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology. 1997; 16(3): 124–33. DOI: 10.1159/000109681
    Back to article
  149. 149Bain P, Brin M, Deuschl G, Elble R, Jankovic J, Findley L, et al. Criteria for the diagnosis of essential tremor. Neurology. 2000; 54(11 Suppl 4): S7.
    Back to article
  150. 150Louis ED, Ford B, Frucht S, Barnes LF, X-Tang M, Ottman R. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Annals of neurology. 2001; 49(6): 761–9. DOI: 10.1002/ana.1022
    Back to article
DOI: https://doi.org/10.5334/tohm.67 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Nov 25, 2019
Accepted on: Apr 15, 2020
Published on: Jun 11, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
essential tremor,
genetic polymorphism,
single nucleotide polymorphism,
variant,
tremor,
hyperkinetic movements,
movement disorders

© 2020 Vasileios Siokas, Athina-Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Paraskevi Aslanidou, Metaxia Dastamani, Alexandros G. Brotis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou, Efthimios Dardiotis, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 10 (2020): Issue 0Next article